BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen KL, Qiu YW, Yang M, Wang T, Yang Y, Qiu HZ, Sun T, Wang WT. Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection. World J Gastroenterol 2024; 30(48): 5130-5151 [PMID: 39735268 DOI: 10.3748/wjg.v30.i48.5130]
URL: https://www.wjgnet.com/1948-9366/full/v30/i48/5130.htm
Number Citing Articles
1
Zejin Zhao, Yue Xiao, Chen-guang Su, Hui Zhao, Jian Li, Jinlong Liu. Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective studyFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1661923
2
Chunchun Yu, Lefu Chen, Wanting Hu, Xiong Lei, Xiling Liu, Zhixiao Xu, Chengshui Chen, Hongjun Zhao. The role of the advanced lung cancer inflammation index (ALI) in the risk of liver fibrosis and mortality among US adult MAFLD patients: a cross-sectional study of NHANES 1999–2018BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03762-w
3
Zhao-Nan Zhang, Liang Hao, Shuang Han, Shan-Shan Li, Si-Xiang Lin, Yan-Dong Miao. Harnessing the prognostic power of preoperative systemic immune-inflammation index/albumin ratio in hepatocellular carcinoma resectionWorld Journal of Gastrointestinal Surgery 2025; 17(2): 102261 doi: 10.4240/wjgs.v17.i2.102261